Belzutifan Improves Symptoms and Extends Time to Treatment D

Belzutifan treatment led to improved quality of life outcomes vs treatment with everolimus in patients with advanced renal cell carcinoma.

Related Keywords

Thomas Powles , Barts Cancer Center , Queen Mary University Of London , Functional Assessment , Queen Mary University , Belzutifan , Quality Of Life Outcomes , Everolimus , Patients With Advanced Renal Cell Carcinoma , Litespark 005 Trial , Nct04195750 , D , Bbs , Orcp ,